Gerard Pernes

Gerard Pernes

Auto-generated profile, based on publicly available information

Gerard Pernes

Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2024 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
PMPooranee K. Morgan
Pooranee K. Morgan
GPGerard Pernes
Gerard Pernes
KHKevin Huynh
Kevin Huynh
CGCorey Giles
Corey Giles
SPSudip Paul
Sudip Paul
AMAndrew Murphy
Andrew Murphy

17 July 2023 in Nature Cardiovascular Research
Verified
Journal Article
Closed access
PDF file
MBMaria N. Barrachina
Maria N. Barrachina
GPGerard Pernes
Gerard Pernes
IBIsabelle C. Becker
Isabelle C. Becker
IAIsabelle Allaeys
Isabelle Allaeys
THThomas I. Hirsch
Thomas I. Hirsch
KMKellie R. Machlus
Kellie R. Machlus

17 April 2025 in Journal of Lipid Research
Verified
Journal Article
Open access
SPSudip Paul
Sudip Paul
PMPooranee Morgan
Pooranee Morgan
GPGerard Pernes
Gerard Pernes
YSYvette Schooneveldt
Yvette Schooneveldt
TDThy Duong
Thy Duong
Peter MeiklePeter Meikle
Peter Meikle
Plasmalogens are a distinct subclass of glycerophospholipids that exhibit unique structural features, notably possessing a vinyl ether linkage at the sn1 position of the glycerol backbone. These specialised lipids play crucial roles in various biological functions. Although the biosynthetic pathway of plasmalogens has been well-characterised, their catabolism remains less studied. In this study, we investigated the impact of global and tissue-specific loss-of-function of a plasmalogen catabolising enzyme, lysoplasmalogenase (TMEM86B), on circulatory and tissue lipidomes. We generated both global and hepatocyte-specific Tmem86b knockout mice using cre-loxP technology. Mice with homozygous global inactivation of Tmem86b (Tmem86b KO mice) were viable and did not display any marked phenotypic abnormalities. Tmem86b KO mice demonstrated significantly elevated levels of the plasmalogens, alkenylphosphatidylethanolamine (PE(P)) and alkenylphosphatidylcholine (PC(P)), as well as lysoplasmalogens, in the plasma, liver, and natural killer cells compared to their wild-type counterparts. The endogenous alkenyl chain composition of plasmalogens remained unaltered in Tmem86b KO mice. Consistent with the global knockout findings, hepatocyte-specific Tmem86b knockout mice also exhibited increased plasmalogen levels in the plasma and liver compared to their floxed control counterparts. Overall, our findings shed light on the role of Tmem86b in plasmalogen catabolism, demonstrating how its ablation leads to an increase in select tissues and cells. This study enhances our understanding of the regulatory mechanisms governing plasmalogen metabolism and highlights the potential of targeting Tmem86b to therapeutically raise plasmalogen levels.

14 July 2026 in Nature Metabolism
Verified
Journal Article
Open access
PDF file
JTJiayin Tang
Jiayin Tang
GPGerard Pernes
Gerard Pernes
BNBrenda Nakagaki
Brenda Nakagaki
NTNhien Tran
Nhien Tran
LBLaura Bokor
Laura Bokor
EMEvanna L. Mills
Evanna L. Mills
Thermogenic brown and beige adipose tissues are important in maintaining metabolic health because of their distinct ability to catabolize stored fat and circulating glucose in futile cycles1,2. Macrophages, present in brown adipose tissue, have been reported to both positively and negatively regulate thermogenic adipocyte function through mechanisms that are incompletely understood3,4,5,6,7,8,9,10,11,12,13,14. Here we show that the macrophage-derived metabolite, itaconate, acts as a paracrine signal to repress adipose tissue thermogenesis in mice. Mechanistically, itaconate inhibits thermogenesis by antagonizing uptake of the pro-thermogenic metabolite, succinate, into brown adipose tissue. These findings reveal an unexpected mechanism for local control of thermogenesis in vivo that relies on paracrine itaconate signalling and demonstrate that the important signalling roles of itaconate extend beyond immunological processes to the regulation of energy balance.